Ponoi II Management, LLC
Follow13F filer, CIK 1746488, San Francisco, CA
Ponoi II Management, LLC reported $123,394,000 across 5 holdings for the quarter ended 2021-06-30, in a 13F-HR filed 2021-08-16.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-21-011466
- Period
- 2021-06-30
- Reported value
- $123M
- Holdings
- 5
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Holdings, Q2 2021
Share positions as resolved from 13F-HR 0000950123-21-011466, largest first. % of portfolio is the value over $123,394,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| CONSTELLATION PHARMACEUTICALCONSTELLATION PHARMACEUTICAL | 1,574,229 | $53.2M | 43.12% | 0 | |||
| NGM BIOPHARMACEUTICALS INCNGM BIOPHARMACEUTICALS INC | 1,298,908 | $25.6M | 20.76% | 0 | |||
| RVMDREVOLUTION MEDICINES INC | 685,011 | $21.7M | 17.62% | 0 | Timeline | ||
| NRIXNURIX THERAPEUTICS INC | 686,274 | $18.2M | 14.76% | 0 | Timeline | ||
| RAPT THERAPEUTICS INCRAPT THERAPEUTICS INC | 145,401 | $4.62M | 3.75% | 0 |
How Q2 2021 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950123-21-011466 | base | 2021-08-16 | acceptance time not in the bulk data set |